Nosocomial bloodstream infections caused by Streptococcus pneumoniae

Clinical Microbiology and Infection

Volumn 11, Issue 11, 2005, Pages 919-924

  Bouza, E ^a   Pintado, V ^b   Rivera, S ^a   Blazquez R ^b   Munoz P ^a   Cercenado, E ^a   Loza, E ^b   Rodriguez Creixems M ^a   Moreno, S ^b   Pallares, R ^c   Garcia E ^c   Casal, J ^c   Fenoll, A ^c   de la Campa, A G ^c   Baquero, F ^c   Soriano, F ^c   Prieto, J ^c   Linares J ^c   Garau, J ^c   Martinez Lacasa J ^c   Latorre, C ^c   Perez Trallero E ^c   Garcia de Lomas J ^c   Fleites, A ^c   more..

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c NONE

Author keywords

Bacteraemia; Bloodstream infection; Nosocomial infection; Pneumococci; Risk factors; Streptococcus pneumoniae

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; ERYTHROMYCIN; GLYCOPEPTIDE; MACROLIDE; PENICILLIN DERIVATIVE; POLYSACCHARIDE VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; HEART FAILURE; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION SENSITIVITY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MENINGITIS; MULTIPLE ORGAN FAILURE; PERITONITIS; PNEUMONIA; POLYPHARMACY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SEPTIC SHOCK; SEROTYPE; SPAIN; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TEACHING HOSPITAL;

HUMAN IMMUNODEFICIENCY VIRUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 27544497708     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01260.x     Document Type: Article

References (42)

1. Folkersen BH, Hojbjerg T, Urth TR, Schonheyder HC. Nosocomial infections with penicillin-resistant Streptococcus pneumoniae. Four clusters with pneumococci serotype 9V. Ugeskr Laeger 2001; 163: 2362-2365.
2. Farinas-Alvarez C, Farinas MC, Garcia-Palomo JD et al. Prognostic factors for pneumococcal bacteremia in a university hospital. Eur J Clin Microbiol Infect Dis 2000; 19: 733-741.
3. Rubins JB, Cheung S, Carson P, Rubins HB, Janoff EN. Identification of clinical risk factors for nosocomial pneumococcal bacteremia. Clin Infect Dis 1999; 29: 178-183.
4. Alvarez S, Guarderas J, Shell CG, Holtsclaw-Berk S, Berk SL. Nosocomial pneumococcal bacteremia. Arch Intern Med 1986; 146: 1509-1512.
5. Mylotte JM, Beam TR. Comparison of community-acquired and nosocomial pneumococcal bacteremia. Am Rev Respir Dis 1981; 123: 265-268.
6. Ruben FL, Norden CW, Korica Y. Pneumococcal bacteremia at a medical/surgical hospital for adults between 1975 and 1980. Am J Med 1984; 77: 1091-1094.
7. Chang JI, Mylotte JM. Pneumococcal bacteremia. Update from an adult hospital with a high rate of nosocomial cases. J Am Geriatr Soc 1987; 35: 747-754.
8. Canet JJ, Juan N, Xercavins M, Freixas N, Garau J. Hospital-acquired pneumococcal bacteremia. Clin Infect Dis 2002; 35: 697-702.
9. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th edn. Approved standard M07-A6. MIC testing supplementary tables. Wayne, PA: NCCLS, 2003.
10. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Cont 1988; 16: 128-140.
11. Crowe MJ, Cooke EM. Review of case definitions for nosocomial infection - towards a consensus. Presentation by the Nosocomial Infection Surveillance Unit (NISU) to the Hospital Infection Liaison Group, subcommittee of the Federation of Infection Societies (FIS). J Hosp Infect 1998; 39: 3-11.
12. McCabe WR, Jackson GG. Gram-negative bacteremia I. Etiology and ecology. Arch Intern Med 1962; 110: 847-855.
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829.
15. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655.
16. Schroeder M, Cooper G. An epidemic of cold, bronchitis and pneumonia due to type V pneumococci. J Infect Dis 1930; 46: 384-392.
17. Stoneburner LI, Finland M. Pneumococcic pneumonia complicating operations and trauma. JAMA 1941; 116: 1497-1504.
18. Durand ML, Calderwood SB, Weber DJ et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328: 21-28.
19. Eykyn SJ, Gransden WR, Phillips I. The causative organisms of septicaemia and their epidemiology. J Antimicrob Chemother 1990; 25(suppl C): 41-58.
20. Bert F, Lambert-Zechovsky N. Microbiology of nosocomial sinusitis in intensive care unit patients. J Infect 1995; 31: 5-8.
21. Anonymous. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Cont 1996; 24: 380-388.
22. Pallares R, Linares J, Vadillo M et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333: 474-480.
23. Garcia-Leoni ME, Cercenado E, Rodeno P, Bernaldo de Quiros JC, Martinez-Hernandez D, Bouza E. Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis 1992; 14: 427-435.
24. Paradisi F, Corti G. Is Streptococcus pneumoniae a nosocomially acquired pathogen? Infect Cont Hosp Epidemiol 1998; 19: 578-580.
25. Paradisi F, Corti G, Cinelli R. Streptococcus pneumoniae as an agent of nosocomial infection: treatment in the era of penicillin-resistant strains. Clin Microbiol Infect 2001; 7(suppl 4): 34-42.
26. Berk SL, Gallemore GM, Smith JK. Nosocomial pneumococcal pneumonia in the elderly. J Am Geriatr Soc 1981; 29: 319-321.
27. Davies AJ, Lockley MR. A prospective survey of hospital cross-infection with Streptococcus pneumoniae. J Hosp Infect 1987; 9: 162-168.
28. Rodriguez-Creixems M, Berto J, Munoz P, Alonso R, Alcala L, Bouza E. Increased incidence of pneumococcal bloodstream infections. Pediatr Infect Dis J 2003; 22: 661-663.
29. Ekdahl K, Martensson A, Kamme C. Bacteraemic pneumococcal infections in Southern Sweden 1981-96: trends in incidence, mortality, age-distribution, serogroups and penicillin-resistance. Scand J Infect Dis 1998; 30: 257-262.
30. Breiman RF, Spika JS, Navarro VJ, Darden PM, Darby CP. Pneumococcal bacteremia in Charleston County, South Carolina. A decade later. Arch Intern Med 1990; 150: 1401-1405.
31. Arpi M, Renneberg J, Andersen HK, Nielsen B, Larsen SO. Bacteremia at a Danish university hospital during a twenty-five-year period (1968-92). Scand J Infect Dis 1995; 27: 245-251.
32. Eskola J, Takala AK, Kela E, Pekkanen E, Kalliokoski R, Leinonen M. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 1992; 268: 3323-3327.
33. Dagan R, Engelhard D, Piccard E, Englehard D. Epidemiology of invasive childhood pneumococcal infections in Israel. The Israeli Pediatric Bacteremia and Meningitis Group. JAMA 1992; 268: 3328-3332.
34. Vaqueiro Subirats M, Sampere Valero M, Font Creus B, Serrate Sanmiguel G, Fontanals Aymerich D, Segura Porta F. Pneumococcal bacteremia in patients aged over 65 years. A study of 161 cases. Med Clin (Barc) 2001; 117: 241-245.
35. Yu VL, Chiou CC, Feldman C et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003; 37: 230-237.
36. Alvarez S, Shell CG, Woolley TW, Berk SL, Smith JK. Nosocomial infections in long-term facilities. J Gerontol 1988; 43: M9-M17.
37. Musher DM, Alexandraki I, Graviss EA et al. Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study. Medicine (Baltimore) 2000; 79: 210-221.
38. Metlay JP, Hofmann J, Cetron MS et al. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2000; 30: 520-528.
39. Steffen S, Herringshaw M. Fulminate pneumococcal septicemia in the asplenic patient: a case study with urgent implications for recognition and prevention. J Emerg Nurs 1999; 25: 102-106.
40. Silverstein M, Bachur R, Harper MB. Clinical implications of penicillin and ceftriaxone resistance among children with pneumococcal bacteremia. Pediatr Infect Dis J 1999; 18: 35-41.
41. Waterer GW, Somes GW, Wunderink RG. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 2001; 161: 1837-1842.
42. Martinez JA, Horcajada JP, Almela M et al. Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2003; 36: 389-395.